InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Friday, 12/29/2017 8:33:51 AM

Friday, December 29, 2017 8:33:51 AM

Post# of 462152
On the bright side, I think (if/when) the new FDA process guidance is written and implemented we will see a MUCH lower risk investment profile. Not just for AVXL but all Biotec's.

We should see stronger PIII prep/analysis work where sponsors/operators and FDA understand better/exactly what they are looking for. There should be fewer failures and (BTW) fewer attempts by those who do not make the cut. FUD should decrease as the antidote(s) information, knowledge and competence kick in.

Maybe biotec investment will be as predictable as GE or CSCO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News